
GENERIC NAME: acarbose
BRAND NAME: Precose
DRUG CLASS AND MECHANISM: Acarbose is an oral medication that is used to control blood glucose (sugar) levels in type II diabetes. It belongs to a class of drugs called alpha-glucosidase inhibitors which also includes miglitol
(Glyset). Acarbose was approved by the FDA for use in 1995.
Carbohydrates that are eaten are digested by enzymes in the intestine into smaller sugars which are absorbed into the body and
increase blood sugar levels. The process of carbohydrate digestion requires the pancreas to release into the intestine alpha-amylase
enzymes which digest the large carbohydrates into smaller carbohydrates called oligosaccharides. The cells lining the small intestine
then release alpha-glucosidase enzymes that further digest the oligosaccharides into smaller sugars, like glucose, that can be absorbed.
Acarbose is a man-made oligosaccharide designed to slow down the actions of alpha-amylase and alpha-glucosidase enzymes thereby slowing
the appearance of sugar in the blood after a meal.
GENERIC: no
PRESCRIPTION: yes
PREPARATIONS: Tablets: 25, 50 and 100 mg.
STORAGE: Acarbose should be stored at room temperature, 15-30°C(59-86°F) in a tight container.
PRESCRIBED FOR: It is believed that strict sugar control in diabetics decreases the risk of eye, kidney, and nerve damage.
Alpha-glucosidase inhibitors are used to help lower blood sugar levels that are not controlled by diet and exercise. Acarbose can be
used alone to treat type II diabetes or can
be combined with sulfonylureas such as glyburide
(Diabeta) or metformin (Glucophage) or
with insulin.
DOSING: The initial acarbose dose may start 25 mg three times daily and then increase after four to
eight weeks to 50-100 mg three times daily. Acarbose should be taken at the first bite of each meal.
Smaller doses may be adequate for patients with severe kidney dysfunction or liver disease. Acarbose is not recommended
if cirrhosis is present. Acarbose therapy is not advised in the presence of certain medical conditions such as inflammatory
bowel disease or intestinal obstruction and chronic intestinal diseases that interfere with digestion or absorption such
as Crohn's disease.
Acarbose doses should be adjusted based upon blood glucose levels taken one hour after a meal and blood HbA1c levels taken about
three months after starting or changing the dose. (HbA1c is a chemical in the blood that is a good indicator of blood glucose control.)
DRUG INTERACTIONS: Acarbose may interfere with digoxin absorption
thereby decreasing digoxin blood levels and its effect. Therefore, the digoxin dose may need to be increased if acarbose is begun.
Since adding insulin or a sulfonylurea to acarbose therapy may lower blood glucose more than acarbose alone,
the risk for developing hypoglycemia is greater when these drugs are combined.
Caution should be used when combining these drugs.
If mild to moderate hypoglycemia occurs while taking acarbose in combination with another anti-diabetic agent,
the hypoglycemia should be treated with oral glucose (dextrose) instead of sucrose (table sugar) because acarbose blocks
the digestion of sucrose to glucose, and hypoglycemia will not be corrected rapidly with sucrose. Acarbose alone does not
produce hypoglycemia.
PREGNANCY: There are no studies of acarbose treatment during pregnancy in humans.
Insulin therapy is recommended in pregnancy.
NURSING MOTHERS: Acarbose is excreted in the milk of lactating animals, but no human studies
have been conducted. Acarbose use is not recommended for nursing mothers.
SIDE EFFECTS: The most common side effects with acarbose therapy
are abdominal pain, diarrhea
and
flatulence. There is a rare possibility that these gastrointestinal side effects may become severe and progress to paralytic ileus.
Other possible but rare side effects are an increase in liver enzymes, and decreases in hematocrit, calcium or vitamin B6 levels.
Last Editorial Review: 4/28/2001 11:14:00 AM
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
 |
 |
From the Doctors at MedicineNet.com  |
 |
 |
- miglitol, Glyset - Source:MedicineNet
- Diabetes - Information on Diabetes (Diabetes Mellitus) including types, causes, symptoms of diabetes, medications, and treatment. Produced by the doctors of MedicineNet.com Source:MedicineNet
- Diabetes Treatment - Learn about the different treatments for diabetes including: medications, insulin, insulin pumps, inhaled insulin, and insulin pens. Source:MedicineNet
- Read 19 more acarbose related articles ...
|
| |
 |
Back to Medications Index